1 unknown. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Unknown 1 |
Follow Gray Zone Lymphoma: new trials by email Literature Review of Gray Zone Lymphoma trials Research Report on Gray Zone Lymphoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Prospective Study of PD-1 Inhibitor Combined With ICE in the Treatment of Relapsed/Refractory Gray Area Lymphoma PD-1 inhibitor +ICE - Gray Zone Lymphoma, Relapse/Recurrence | Phase 2 | Unknown | Zhejiang Cancer Hospital | 20 | 2021-05-01 | 2021-04-27 |
Recurrence (1)
Disease Attributes (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1)
Carboplatin (1) · Etoposide (1)
Cong Li (1)